KYAT3
Kynurenine--oxoglutarate transaminase 3
Also known as: CCBL2, KAT3, KAT3_HUMAN, KATIII, RBM1, RP11-82K18.3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6YP21
- Gene
- KYAT3
- Ensembl
- ENSG00000137944
- Chromosome
- 1
- Canonical length
- 454 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoli,Cytokinetic bridge,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes an aminotransferase that transaminates kynurenine to form kynurenic acid, which is a metabolite of tryptophan. Multiple alternatively spliced transcript variants that encode different proteins have been described for this gene. This gene shares 5' exon structure with the RNA binding motif protein, X-linked-like 1 locus on chromosome 1, but the coding sequences are non-overlapping. [provided by RefSeq, Mar 2017]
Canonical amino-acid sequenceUniProt
454 residues, UniProt reviewed canonical sequence.
>Q6YP21|KYAT3
1 MFLAQRSLCS LSGRAKFLKT ISSSKILGFS TSAKMSLKFT NAKRIEGLDS NVWIEFTKLA
61 ADPSVVNLGQ GFPDISPPTY VKEELSKIAA IDSLNQYTRG FGHPSLVKAL SYLYEKLYQK
121 QIDSNKEILV TVGAYGSLFN TIQALIDEGD EVILIVPFYD CYEPMVRMAG ATPVFIPLRS
181 KPVYGKRWSS SDWTLDPQEL ESKFNSKTKA IILNTPHNPL GKVYNREELQ VIADLCIKYD
241 TLCISDEVYE WLVYSGNKHL KIATFPGMWE RTITIGSAGK TFSVTGWKLG WSIGPNHLIK
301 HLQTVQQNTI YTCATPLQEA LAQAFWIDIK RMDDPECYFN SLPKELEVKR DRMVRLLESV
361 GLKPIVPDGG YFIIADVSLL DPDLSDMKNN EPYDYKFVKW MTKHKKLSAI PVSAFCNSET
421 KSQFEKFVRF CFIKKDSTLD AAEEIIKAWS VQKSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KYAT3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 31 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 31 nTPM
- kidney: 29 nTPM
- pancreas: 28 nTPM
- breast: 28 nTPM
- ovary: 27 nTPM
- liver: 26 nTPM
Single-cell type
- syncytiotrophoblasts: 129 nCPM
- sertoli cells: 120 nCPM
- cytotrophoblasts: 110 nCPM
- migrating cytotrophoblasts: 101 nCPM
- neutrophils: 97 nCPM
- pancreatic acinar cells: 87 nCPM
Immune cell
- myeloid DC: 16 nTPM
- T-reg: 16 nTPM
- classical monocyte: 12 nTPM
- NK-cell: 11 nTPM
- MAIT T-cell: 11 nTPM
- memory CD4 T-cell: 11 nTPM
Brain region
- choroid plexus: 18 nTPM
- cerebellum: 14 nTPM
- cerebral cortex: 13 nTPM
- midbrain: 13 nTPM
- hypothalamus: 13 nTPM
- pons: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.34
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 2-oxoglutarate metabolic process
- amino acid metabolic process
- kynurenine metabolic process
- L-kynurenine catabolic process
Molecular functions
- cysteine-S-conjugate beta-lyase activity
- kynurenine-glyoxylate transaminase activity
- kynurenine-oxoglutarate transaminase activity
- protein homodimerization activity
- pyridoxal phosphate binding
- RNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KYAT3 as an antibody target. Whether an autoantibody or antibody against KYAT3 could matter depends on whether native KYAT3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KYAT3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label KYAT3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...